title: Re: Tamoxifen and contralateral breast cancer: the other side.
authors.forename: C I
authors.initials: CI
authors.lastname: Li
authors.forename: K E
authors.initials: KE
authors.lastname: Malone
authors.forename: N S
authors.initials: NS
authors.lastname: Weiss
authors.forename: J R
authors.initials: JR
authors.lastname: Daling
mesh_terms: D000368:Aged; D015982:Bias; D001943:Breast Neoplasms / Q000145:classification / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D005260:Female; D006801:Humans; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D008954:Models, Biological; D009364:Neoplasm Recurrence, Local / Q000209:etiology; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D011960:Receptors, Estrogen / Q000378:metabolism*; D015203:Reproducibility of Results; D012307:Risk Factors; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D011960:Receptors, Estrogen; D013629:Tamoxifen